Trial Profile
A study to evaluate denosumab for the treatment of osteoporosis in postmenopausal women previously treated with ibandronate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Ibandronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 14 Dec 2015 New trial record